Bespoke Extracts, Inc.

CIK 1409197 BSPK·Pharmaceutical Preparations · All EDGAR filings ↗

Refine

Late filing elevated Filing comparison 2026-08-17

Bespoke Extracts, Inc. filed its quarterly report late and said it expects a significant change in results

expects significant change in results 3 days past the statutory due date. other reports also outstanding

The Company requires additional time to complete the preparation of the financial statements and related disclosures required to be included in those reports. The interim financial statements to be included in the Form 10-Q for the quarter ended June 30, 2026 include a balance sheet as of December 31, 2025 derived from the Company's audited financial statements for that year, and the Form 10-Q for the quarter ended March 31, 2026 is required to be filed first. Accordingly, the Company is unable to complete and file the Form 10-Q for the quarter ended June 30, 2026 until those reports have been completed.

Evidence

Anticipates significant change: Yes
Days past due date: 3
Other periodic reports filed: No
Routine: No
Severity: elevated
Source: Form 12b-25 (notification of late filing)
Stated reason: The Company requires additional time to complete the preparation of the financial statements and related disclosures required to be included in those reports. The interim financial statements to be included in the Form 10-Q for the quarter ended June 30, 2026 include a balance sheet as of December 31, 2025 derived from the Company's audited financial statements for that year, and the Form 10-Q for the quarter ended March 31, 2026 is required to be filed first. Accordingly, the Company is unable to complete and file the Form 10-Q for the quarter ended June 30, 2026 until those reports have been completed.
Why: The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Late filing elevated Filing comparison 2026-05-18

Bespoke Extracts, Inc. filed its quarterly report late and said it expects a significant change in results

expects significant change in results 3 days past the statutory due date.

These procedures could not be completed by the prescribed due date without unreasonable effort or expense.

Evidence

Anticipates significant change: Yes
Days past due date: 3
Other periodic reports filed: Yes
Routine: No
Severity: elevated
Source: Form 12b-25 (notification of late filing)
Stated reason: These procedures could not be completed by the prescribed due date without unreasonable effort or expense.
Why: The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Late filing high Filing comparison 2026-03-31

Bespoke Extracts, Inc. filed its annual report late and said it expects a significant change in results

expects significant change in results Filed on the statutory due date.

This includes ongoing coordination with its independent registered public accounting firm and internal reviews by management and the audit committee. These processes have imposed time constraints that could not be completed without unreasonable effort or expense to the registrant. The registrant expects to file the Form 10-K no later than fifteen calendar days after the original due date.

Evidence

Anticipates significant change: Yes
Days past due date: 0
Other periodic reports filed: Yes
Routine: No
Severity: high
Source: Form 12b-25 (notification of late filing)
Stated reason: This includes ongoing coordination with its independent registered public accounting firm and internal reviews by management and the audit committee. These processes have imposed time constraints that could not be completed without unreasonable effort or expense to the registrant. The registrant expects to file the Form 10-K no later than fifteen calendar days after the original due date.
Why: The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗